- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00004124
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High-Risk Prostate Cancer Patients Following Radical Prostatectomy
RATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether hormone therapy plus mitoxantrone and prednisone is more effective than hormone therapy alone for prostate cancer.
PURPOSE: This randomized phase III trial is studying hormone therapy, mitoxantrone, and prednisone to see how well they work compared to hormone therapy alone in treating patients who have undergone radical prostatectomy for prostate cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVES:
- Compare the overall and disease-free survival of patients with high-risk adenocarcinoma of the prostate treated with adjuvant androgen deprivation therapy with or without mitoxantrone and prednisone after radical prostatectomy.
- Compare the qualitative and quantitative toxic effects of these regimens in this patient population.
- Compare the prostate-specific antigen (PSA) progression-free survival rate in patient treated with these regimens.
- Determine whether PSA progression is a surrogate endpoint for survival or disease-free survival in this patient population.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to surgical extent of disease (organ confined vs not organ confined, but N0 vs N1), Gleason's sum (less than 7 vs 7 vs greater than 7), and planned radiotherapy (yes vs no). Patients are randomized to one of two treatment arms.
- Arm I:Patients receive goserelin subcutaneously once every 13 weeks (8 injections total) and oral bicalutamide once daily for 2 years in the absence of disease progression or unacceptable toxicity.
- Arm II:Patients receive mitoxantrone IV over 30 minutes on day 1 and oral prednisone twice daily on days 1-21. Treatment repeats every 3 weeks for 6 courses in the absence of disease progression or unacceptable toxicity. Patients also receive hormonal therapy as in arm I beginning concurrently with the initiation of mitoxantrone and prednisone.
Patients may undergo radiotherapy 5 days a week for 6.5-7.8 weeks beginning anytime (arm I) or after completion of chemotherapy (arm II), at the discretion of the physician, in the absence of disease progression or unacceptable toxicity.
Patients are offered the possibility to participate in biomarker research by allowing their tissue/blood to be studied.
Patients are followed every 6 months for 2 years and then annually for up to 13 years.
PROJECTED ACCRUAL: A total of 1,360 patients (680 per treatment arm) will be accrued for this study within 9.5 years.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Providence Cancer Center
-
Anchorage, Alaska, United States, 99508
- Alaska Regional Hospital Cancer Center
-
-
Arizona
-
Glendale, Arizona, United States, 85306
- Banner Thunderbird Medical Center
-
Phoenix, Arizona, United States, 85006
- Banner Good Samaritan Medical Center
-
Phoenix, Arizona, United States, 85006
- CCOP - Western Regional, Arizona
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
-
Springdale, Arkansas, United States, 72764
- Highlands Oncology Group - Springdale
-
-
California
-
Berkeley, California, United States, 94704
- Alta Bates Comprehensive Cancer Center
-
Burlingame, California, United States, 94010
- Peninsula Medical Center
-
Greenbrae, California, United States, 94904
- Marin Cancer Institute at Marin General Hospital
-
Greenbrae, California, United States, 94904
- Sutter Health - Western Division Cancer Research Group
-
Greenbrae, California, United States, 94904
- California Cancer Care, Incorporated
-
San Diego, California, United States, 92134
- Naval Medical Center - San Diego
-
San Francisco, California, United States, 94115
- UCSF Comprehensive Cancer Center
-
San Francisco, California, United States, 94121
- Veterans Affairs Medical Center - San Francisco
-
San Francisco, California, United States, 94118
- California Pacific Medical Center - California Campus
-
San Francisco, California, United States, 94110
- San Francisco General Hospital Medical Center
-
Santa Barbara, California, United States, 93105
- Cancer Center of Santa Barbara
-
Santa Barbara, California, United States, 93105
- Sansum Medical Clinic
-
Santa Barbara, California, United States, 93105
- Santa Barbara Hematology Oncology Medical Group at Cancer Center of Santa Barbara
-
Solvang, California, United States, 93463
- Santa Barbara Hematology Oncology - Solvang
-
Vallejo, California, United States, 94589
- Sutter Solano Medical Center
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80909
- Memorial Hospital
-
Greeley, Colorado, United States, 80631
- North Colorado Medical Center
-
Loveland, Colorado, United States, 80539
- McKee Medical Center
-
-
Connecticut
-
Norwich, Connecticut, United States, 06360
- Eastern Connecticut Hematology and Oncology Associates
-
Stamford, Connecticut, United States, 06904
- Carl and Dorothy Bennett Cancer Center at Stamford Hospital
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
-
-
Georgia
-
Augusta, Georgia, United States, 30912
- MBCCOP - Medical College of Georgia Cancer Center
-
Gainesville, Georgia, United States, 30501
- Northeast Georgia Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96859
- Tripler Army Medical Center
-
-
Illinois
-
Alton, Illinois, United States, 62002
- Saint Anthony's Hospital at Saint Anthony's Health Center
-
Aurora, Illinois, United States, 60507
- Rush-Copley Cancer Care Center
-
Barrington, Illinois, United States, 60010
- Good Shepherd Hospital
-
Chicago, Illinois, United States, 60637-1470
- University of Chicago Cancer Research Center
-
Chicago, Illinois, United States, 60611-3013
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
-
Chicago, Illinois, United States, 60612-7243
- University of Illinois Cancer Center
-
Chicago, Illinois, United States, 60625
- Swedish Covenant Hospital
-
Chicago, Illinois, United States, 60611
- Hematology and Oncology Associates
-
Chicago, Illinois, United States, 60657
- Creticos Cancer Center at Advocate Illinois Masonic Medical Center
-
Chicago, Illinois, United States, 60611
- Veterans Affairs Medical Center - Lakeside Chicago
-
Chicago, Illinois, United States, 60612
- Veterans Affairs Medical Center - Chicago Westside Hospital
-
Chicago, Illinois, United States, 60616
- Mercy Hospital and Medical Center
-
Downers Grove, Illinois, United States, 60515
- Advocate Good Samaritan Hospital
-
Evanston, Illinois, United States, 60201-1781
- Evanston Northwestern Healthcare - Evanston Hospital
-
Hines, Illinois, United States, 60141
- Veterans Affairs Medical Center - Hines
-
Joliet, Illinois, United States, 60435
- Joliet Oncology-Hematology Associates, Limited - West
-
Joliet, Illinois, United States, 60432
- Midwest Center for Hematology/Oncology
-
La Grange, Illinois, United States, 60525
- La Grange Memorial Hospital
-
Libertyville, Illinois, United States, 60048
- North Shore Oncology and Hematology Associates, Limited - Libertyville
-
Maywood, Illinois, United States, 60153
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
-
Mount Vernon, Illinois, United States, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, United States, 60714
- Cancer Care and Hematology Specialists of Chicagoland - Niles
-
Normal, Illinois, United States, 61761
- Mid-Illinois Hematology-Oncology Associates at Community Cancer Center
-
Park Ridge, Illinois, United States, 60068
- Cancer Care Center at Advocate Lutheran Hospital
-
Skokie, Illinois, United States, 60076
- Hematology Oncology Associates - Skokie
-
Skokie, Illinois, United States, 60076
- Hematology/Oncology of the North Shore at Gross Point Medical Center
-
Urbana, Illinois, United States, 61801
- Carle Cancer Center at Carle Foundation Hospital
-
Urbana, Illinois, United States, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Evansville, Indiana, United States, 47714
- Oncology/Hematology Associates of Southwest Indiana at St. Mary's Cancer Center
-
Indianapolis, Indiana, United States, 46202-5289
- Indiana University Cancer Center
-
Michigan City, Indiana, United States, 46360
- Saint Anthony Memorial Health Centers
-
-
Iowa
-
Ames, Iowa, United States, 50010
- McFarland Clinic, PC
-
Cedar Rapids, Iowa, United States, 52402
- St. Luke's Hospital
-
Cedar Rapids, Iowa, United States, 52403
- Cedar Rapids Oncology Associates
-
Cedar Rapids, Iowa, United States, 52403
- Mercy Regional Cancer Center at Mercy Medical Center
-
Waterloo, Iowa, United States, 50702
- Covenant Cancer Treatment Center
-
Waterloo, Iowa, United States, 50702
- Cedar Valley Medical Specialists, PC - West Ridgeway Avenue
-
-
Kansas
-
Chanute, Kansas, United States, 66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City, Kansas, United States, 67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado, Kansas, United States, 67042
- Cancer Center of Kansas, PA - El Dorado
-
Kansas City, Kansas, United States, 64128
- Veterans Affairs Medical Center - Kansas City
-
Kingman, Kansas, United States, 67068
- Cancer Center of Kansas, PA - Kingman
-
Liberal, Kansas, United States, 67901
- Southwest Medical Center
-
Newton, Kansas, United States, 67114
- Cancer Center of Kansas, PA - Newton
-
Parsons, Kansas, United States, 67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt, Kansas, United States, 67124
- Cancer Center of Kansas, PA - Pratt
-
Salina, Kansas, United States, 67042
- Cancer Center of Kansas, PA - Salina
-
Wellington, Kansas, United States, 67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita, Kansas, United States, 67214
- Wesley Medical Center
-
Wichita, Kansas, United States, 67203
- Associates in Womens Health, PA - North Review
-
Wichita, Kansas, United States, 67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita, Kansas, United States, 67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita, Kansas, United States, 67214
- CCOP - Wichita
-
Wichita, Kansas, United States, 67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Winfield, Kansas, United States, 67156
- Cancer Center of Kansas, PA - Winfield
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536-0293
- Markey Cancer Center at University of Kentucky Chandler Medical Center
-
-
Louisiana
-
Monroe, Louisiana, United States, 71210
- Louisiana State University Health Sciences Center - Monroe
-
Shreveport, Louisiana, United States, 71130-3932
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences
-
Shreveport, Louisiana, United States, 71101
- Veterans Affairs Medical Center - Shreveport
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Cancer Research Center at Boston Medical Center
-
Burlington, Massachusetts, United States, 01805
- Lahey Clinic Medical Center - Burlington
-
Worcester, Massachusetts, United States, 01605
- Commonwealth Hematology-Oncology P.C. - Worcester
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-0942
- University of Michigan Comprehensive Cancer Center
-
Ann Arbor, Michigan, United States, 48106-0995
- Saint Joseph Mercy Cancer Center
-
Ann Arbor, Michigan, United States, 48106
- CCOP - Michigan Cancer Research Consortium
-
Big Rapids, Michigan, United States, 49307
- Mecosta County Medical Center
-
Detroit, Michigan, United States, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
Escanaba, Michigan, United States, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
Flint, Michigan, United States, 48503
- Genesys Hurley Cancer Institute
-
Grand Rapids, Michigan, United States, 49503
- CCOP - Grand Rapids
-
Grand Rapids, Michigan, United States, 49503
- Lacks Cancer Center at Saint Mary's Health Care
-
Grand Rapids, Michigan, United States, 49506
- Metro Health Hospital
-
Grand Rapids, Michigan, United States, 49503
- Spectrum Health Hospital - Butterworth Campus
-
Grosse Pointe Woods, Michigan, United States, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Holland, Michigan, United States, 49423
- Holland Community Hospital
-
Iron Mountain, Michigan, United States, 49801
- Green Bay Oncology, Limited - Iron Mountain
-
Jackson, Michigan, United States, 49201
- Foote Hospital
-
Lansing, Michigan, United States, 48909
- Sparrow Regional Cancer Center
-
Muskegon, Michigan, United States, 49442
- Hackley Hospital
-
Petoskey, Michigan, United States, 49770
- Northern Michigan Hospital
-
Port Huron, Michigan, United States, 48060
- Mercy Regional Cancer Center at Mercy Hospital
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital - Royal Oak Campus
-
Saginaw, Michigan, United States, 48601
- Seton Cancer Institute - Saginaw
-
Traverse City, Michigan, United States, 49684
- Munson Medical Center
-
Warren, Michigan, United States, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Alexandria, Minnesota, United States, 56308
-
Brainerd, Minnesota, United States, 56401
- Brainerd Medical Center
-
Brainerd, Minnesota, United States, 56401
- St. Joseph's Medical Center
-
Fergus Falls, Minnesota, United States, 56537
-
Montevideo, Minnesota, United States, 56265
- Chippewa County - Montevideo Hospital
-
Saint Cloud, Minnesota, United States, 56303
- CentraCare Clinic - River Campus
-
Saint Cloud, Minnesota, United States, 56303
- Coborn Cancer Center
-
Sartell, Minnesota, United States, 56377
- Adult and Pediatric Urology, P.L.L.P.
-
-
Missouri
-
Cape Girardeau, Missouri, United States, 63701
- Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital
-
Cape Girardeau, Missouri, United States, 63701
- Saint Francis Medical Center
-
Chesterfield, Missouri, United States, 63017
- Saint Luke's Hospital
-
Kansas City, Missouri, United States, 64131
- CCOP - Kansas City
-
Saint Louis, Missouri, United States, 63131
- Missouri Baptist Cancer Center
-
Saint Louis, Missouri, United States, 63141
- CCOP - St. Louis-Cape Girardeau
-
Saint Louis, Missouri, United States, 63141
- David C. Pratt Cancer Center at St. John's Mercy
-
Saint Louis, Missouri, United States, 63110
- Siteman Cancer Center at Barnes-Jewish Hospital
-
Saint Louis, Missouri, United States, 63141
- Arch Medical Services, Incorporated at Center for Cancer Care Research
-
-
Montana
-
Billings, Montana, United States, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, United States, 59101
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Billings, Montana, United States, 59101
- St. Vincent Healthcare
-
Billings, Montana, United States, 59107-5100
- Billings Clinic Cancer Center
-
Billings, Montana, United States, 59107-7000
- Deaconess Billings Clinic - Downtown
-
Bozeman, Montana, United States, 59715
- Bozeman Deaconess Hospital
-
Butte, Montana, United States, 59701
- St. James Community Hospital
-
Great Falls, Montana, United States, 59405
- Great Falls Clinic
-
Great Falls, Montana, United States, 59405
-
Great Falls, Montana, United States, 59405
- Sletten Regional Cancer Institute at Benefis Healthcare
-
Helena, Montana, United States, 59601
- St. Peter's Hospital
-
Kalispell, Montana, United States, 59901
- Kalispell Regional Medical Center
-
Kalispell, Montana, United States, 59901
- Glacier Oncology, PLLC
-
Kalispell, Montana, United States, 59901
- Kalispell Medical Oncology
-
Missoula, Montana, United States, 59801
- Community Medical Center
-
Missoula, Montana, United States, 59804
- Guardian Oncology and Center for Wellness
-
Missoula, Montana, United States, 59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula, Montana, United States, 59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Kearney, Nebraska, United States, 68848-1990
- Good Samaritan Cancer Center at Good Samaritan Hospital
-
-
Nevada
-
Las Vegas, Nevada, United States, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, United States, 89106
- CCOP - Nevada Cancer Research Foundation
-
-
New Hampshire
-
Keene, New Hampshire, United States, 03431
- Kingsbury Center for Cancer Care at Cheshire Medical Center
-
Laconia, New Hampshire, United States, 03246
- Lakes Region General Hospital
-
Lebanon, New Hampshire, United States, 03756-0002
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
-
Manchester, New Hampshire, United States, 03103
- Elliot Regional Cancer Center at Elliot Hospital
-
Rochester, New Hampshire, United States, 03867
- Frisbie Memorial Hospital
-
-
New Jersey
-
Hamilton, New Jersey, United States, 08690
- Cancer Institute of New Jersey at Hamilton
-
Montclair, New Jersey, United States, 07042
- Mountainside Hospital Cancer Center
-
Morristown, New Jersey, United States, 07962
- Carol G. Simon Cancer Center at Morristown Memorial Hospital
-
New Brunswick, New Jersey, United States, 08903
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131-5636
- University of New Mexico Cancer Research and Treatment Center
-
-
New York
-
Brooklyn, New York, United States, 11209
- Veterans Affairs Medical Center - Brooklyn
-
Buffalo, New York, United States, 14215
- Veterans Affairs Medical Center - Buffalo
-
Rochester, New York, United States, 14642
- James P. Wilmot Cancer Center at University of Rochester Medical Center
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Comprehensive Cancer Center
-
Goldsboro, North Carolina, United States, 27534
- Wayne Memorial Hospital, Incorporated
-
Hendersonville, North Carolina, United States, 28791
- Pardee Memorial Hospital
-
Kinston, North Carolina, United States, 28501
- Lenoir Memorial Cancer Center
-
Rutherfordton, North Carolina, United States, 28139
- Rutherford Hospital
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Bismarck Cancer Center
-
Bismarck, North Dakota, United States, 58501
- Mid Dakota Clinic, PC
-
Bismarck, North Dakota, United States, 58501
- Cancer Care Center at Medcenter One Hospital
-
Bismarck, North Dakota, United States, 58502
- St. Alexius Medical Center
-
-
Ohio
-
Akron, Ohio, United States, 44309-2090
- Akron City Hospital
-
Bryan, Ohio, United States, 43506
- Community Hospitals and Wellness Centers - Bryan
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Taussig Cancer Center
-
Independence, Ohio, United States, 44131
- Community Oncology Group at Cleveland Clinic Cancer Center
-
Lima, Ohio, United States, 45801
- St. Rita's Medical Center
-
Wooster, Ohio, United States, 44691
- Cleveland Clinic - Wooster
-
Youngstown, Ohio, United States, 44501
- Tod Children's Hospital - Forum Health
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- OU Cancer Institute
-
-
Oregon
-
Bend, Oregon, United States, 97701
- St. Charles Medical Center - Bend
-
Gresham, Oregon, United States, 97030
- Legacy Mount Hood Medical Center
-
Milwaukie, Oregon, United States, 97222
- Providence Milwaukie Hospital
-
Portland, Oregon, United States, 97213-2967
- Providence Cancer Center at Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- CCOP - Columbia River Oncology Program
-
Portland, Oregon, United States, 97225
- Providence St. Vincent Medical Center
-
Portland, Oregon, United States, 97210
- Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center
-
Portland, Oregon, United States, 97227
- Legacy Emanuel Hospital and Health Center & Children's Hospital
-
Tualatin, Oregon, United States, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18105
- Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
-
Harrisburg, Pennsylvania, United States, 17105
- PinnacleHealth Regional Cancer Center at Polyclinic Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- Hillman Cancer Center at University of Pittsburgh Cancer Institute
-
-
South Carolina
-
Aiken, South Carolina, United States, 29801
- Cancer Care Institute of Carolina at Aiken Regional Medical Centers
-
Anderson, South Carolina, United States, 29621
- AnMed Health Cancer Center
-
Charleston, South Carolina, United States, 29425
- Hollings Cancer Center at Medical University of South Carolina
-
Charleston, South Carolina, United States, 29401
- Roper St. Francis Cancer Center at Roper Hospital
-
Spartanburg, South Carolina, United States, 29303
- CCOP - Upstate Carolina
-
Spartanburg, South Carolina, United States, 29303
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
-
-
Vermont
-
Berlin, Vermont, United States, 05602
- Mountainview Medical
-
Burlington, Vermont, United States, 05401
- Fletcher Allen Health Care - University Health Center Campus
-
-
Washington
-
Bellingham, Washington, United States, 98225
- St. Joseph Cancer Center
-
Bremerton, Washington, United States, 98310
- Olympic Hematology and Oncology
-
Mount Vernon, Washington, United States, 98273
- Skagit Valley Hospital Cancer Care Center
-
Seattle, Washington, United States, 98104
- Harborview Medical Center
-
Seattle, Washington, United States, 98104
- Fred Hutchinson Cancer Research Center
-
Seattle, Washington, United States, 98104
- Minor and James Medical, PLLC
-
Seattle, Washington, United States, 98112
- Group Health Central Hospital
-
Seattle, Washington, United States, 98122-4307
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
-
Seattle, Washington, United States, 98122
- Polyclinic First Hill
-
Seattle, Washington, United States, 98195-6043
- University Cancer Center at University of Washington Medical Center
-
Sedro-Woolley, Washington, United States, 98284
- North Puget Oncology at United General Hospital
-
Spokane, Washington, United States, 99202
- Cancer Care Northwest - Spokane South
-
Spokane, Washington, United States, 99204-2967
- Rockwood Clinic Cancer Treatment Center
-
Tacoma, Washington, United States, 98431
- Madigan Army Medical Center - Tacoma
-
Vancouver, Washington, United States, 98668
- Southwest Washington Medical Center Cancer Center
-
Wenatchee, Washington, United States, 98801-2028
- Wenatchee Valley Medical Center
-
Yakima, Washington, United States, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
-
Wisconsin
-
Appleton, Wisconsin, United States, 54911-3496
- Fox Valley Hematology and Oncology - East Grant Street
-
Green Bay, Wisconsin, United States, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, United States, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
Green Bay, Wisconsin, United States, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital
-
Madison, Wisconsin, United States, 53792-6164
- University of Wisconsin Comprehensive Cancer Center
-
Madison, Wisconsin, United States, 53717
- Dean Medical Center - Madison
-
Marinette, Wisconsin, United States, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Oconto Falls, Wisconsin, United States, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Sturgeon Bay, Wisconsin, United States, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
Wausau, Wisconsin, United States, 54401
- University of Wisconcin Cancer Center at Aspirus Wausau Hospital
-
-
Wyoming
-
Sheridan, Wyoming, United States, 82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
DISEASE CHARACTERISTICS:
Histologically confirmed stage T1-T3 adenocarcinoma of the prostate before radical prostatectomy and lymph node dissection
- Must have undergone prostatectomy within the past 120 days
Must meet at least 1 of the following pathologic criteria:
- Gleason sum at least 8
- pT3b (seminal vesicle), pT4, or N1
- Gleason sum of 7 and positive margin
- Preoperative PSA greater than 15 ng/mL, Gleason score greater than 7, or PSA level greater than 10 ng/mL and Gleason score greater than 6
- Must have an undetectable PSA (no greater than 0.2 ng/mL) documented after surgery or prior to adjuvant hormonal therapy (for patients initiating adjuvant hormonal therapy prior to study)
- No evidence of metastatic disease on bone scan if PSA is 20 ng/mL or greater at clinical diagnosis
- No distant metastatic disease
PATIENT CHARACTERISTICS:
Performance status:
- SWOG 0-1
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Cardiovascular:
- No uncontrolled congestive heart failure
- If history of cardiac disease, LVEF at least 50% by MUGA scan or 2-D echocardiogram
Other:
- No HIV positivity
- No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer or stage I or II cancer that is currently in complete remission
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine therapy:
- Prior neoadjuvant hormonal therapy of no more than 4 months duration before radical prostatectomy allowed
- Other concurrent adjuvant hormonal therapy allowed if initiated prior to study
- Concurrent low-dose megestrol (less than 40 mg/day) for hot flashes allowed
Radiotherapy:
- No prior radiotherapy
- No concurrent whole pelvis irradiation
- Concurrent radiotherapy allowed at the discretion of the physician
Surgery:
- See Disease Characteristics
- See Endocrine therapy
- Recovered from prior surgery
Other:
- No other prior or concurrent therapy for adenocarcinoma of the prostate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: bicalutamide, goserelin
androgen deprivation
|
Other Names:
Other Names:
|
Experimental: bicalutamide, goserelin, mitoxantrone, prednisone
androgen deprivation plus mitoxantrone, prednisone
|
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Survival
Time Frame: at 10 Years
|
Measured from date of randomization to date of death from any cause.
Patient known to be alive are censored at date of last contact.
|
at 10 Years
|
Disease Free Survival
Time Frame: at 10 Years
|
Measured from date of randomization to date of first observation of recurrence or death due to any cause.
Patients without recurrence are censored at date of last contact.
|
at 10 Years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare Qualitative and Quantitative Toxicities of These Regimens in These Patients
Time Frame: Up to 22 months from registration
|
Number of patients with adverse events that are related to study drug
|
Up to 22 months from registration
|
PSA Progression Free Survival
Time Frame: Up to 10 Years
|
Measured from date of randomization to date of PSA progression or death due to any cause.
PSA progression is defined as a serum PSA level of > 0.2 ng/mL measured on 3 consecutive occasions or in the absence of increasing PSA, a positive bone scan result or other radiographic or histologic evidence of progression will be used.
Date of progression will be the date that the first measure of increasing PSA is noted in the series of 3.
|
Up to 10 Years
|
PSA Progression as Surrogate Endpoint for Overall Survival or Disease Free Survival
Time Frame: Up to 10 Years
|
Up to 10 Years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: L. Michael Glode, MD, University of Colorado, Denver
- Study Chair: Nancy A. Dawson, MD, University of Maryland Greenebaum Cancer Center
Publications and helpful links
General Publications
- Glode LM, Tangen CM, Hussain MH, et al.: Southwest Oncology Group S9921: prolonged event-free survival in high-risk prostate cancer (PC) patients receiving adjuvant androgen deprivation. [Abstract] J Clin Oncol 27 (Suppl 15): A-5009, 2009.
- Flaig TW, Tangen CM, Hussain MH, Stadler WM, Raghavan D, Crawford ED, Glode LM; Southwest Oncology Group. Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial. J Clin Oncol. 2008 Mar 20;26(9):1532-6. doi: 10.1200/JCO.2007.13.4197.
- Glode LM, Hussain MH, Benson MC, et al.: SWOG 9921: a phase III multi-institutional trial of adjuvant therapy for high risk prostate cancer after radical prostatectomy. [Abstract] American Society of Clinical Oncology 2007 Prostate Cancer Symposium, 22-24 February 2007, Orlando, FL. A-349, 2007.
- Hussain M, Tangen CM, Thompson IM Jr, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM. Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921. J Clin Oncol. 2018 May 20;36(15):1498-1504. doi: 10.1200/JCO.2017.76.4126. Epub 2018 Apr 6. Erratum In: J Clin Oncol. 2018 Jul 10;36(20):2131.
- Dorff TB, Flaig TW, Tangen CM, Hussain MH, Swanson GP, Wood DP Jr, Sakr WA, Dawson NA, Haas NB, Crawford ED, Vogelzang NJ, Thompson IM, Glode LM. Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study. J Clin Oncol. 2011 May 20;29(15):2040-5. doi: 10.1200/JCO.2010.32.2776. Epub 2011 Apr 18.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Genital Neoplasms, Male
- Prostatic Diseases
- Prostatic Neoplasms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
- Hormone Antagonists
- Androgen Antagonists
- Goserelin
- Prednisone
- Bicalutamide
- Mitoxantrone
Other Study ID Numbers
- CDR0000067352
- U10CA032102 (U.S. NIH Grant/Contract)
- S9921 (Other Identifier: SWOG)
- CALGB-99904 (Other Identifier: CALGB)
Plan for Individual participant data (IPD)
Study Data/Documents
-
Individual Participant Data Set
Information comments: Data Available: Select individual patient-level data from this trial can be requested from the NCTN/NCORP Data Archive.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on mitoxantrone hydrochloride
-
Institute of Hematology & Blood Diseases Hospital...CSPC Ouyi Pharmaceutical Co., Ltd.Active, not recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingPeripheral T Cell LymphomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany
-
Hui ZengCSPC Ouyi Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Withdrawn
-
Lederle LaboratoriesCompletedHIV Infections | Sarcoma, KaposiUnited States
-
Hope Cancer Institute, Inc.UnknownProstate CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Suspended
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown